- 英文名称(3R,3Ar,6R,7Ar,8R)-7A-Hydroxy-8-(4-Hydroxy-3-Methoxyphenyl)-4-((2R,3R)-3,5,7-Trihydroxy-4-Oxochroman-2-yl)-3,3A,6,7A-Tetrahydro-3,6-Methanobenzofuran-7(2H)-One
- 中文名称水飞蓟宁
- IUPAC名称(3R,3aR,6R,7aR,8R)-7a-hydroxy-8-(4-hydroxy-3-methoxyphenyl)-4-((2R,3R)-3,5,7-trihydroxy-4-oxochroman-2-yl)-2,3,3a,7a-tetrahydro-3,6-methanobenzofuran-7(6H)-one
- 其它别名3,6-Methanobenzofuran-7(6H)-one,4-(3,4-dihydro-3,5,7-trihydroxy-4-oxo-2H-1-benzopyran-2-yl)-2,3,3a,7a-tetrahydro-7a-hydroxy-8-(4-hydroxy-3-methoxyphenyl)-,[3R-[3a,3ab,4(2R*,3R*),6a,7ab,8R*]]-; 3,6-Methanobenzofuran-7(6aH)-one, 2,3a,3aa,7a-tetrahydro-7aa-hydroxy-8-(4-hydroxy-3-methoxyphenyl)-4-(3a,5,7-trihydroxy-4-oxo-2b-chromanyl)-, (+)- (8CI); Silidianin; Silidianine; Silydianin
- CAS编号29782-68-1
- MFCD编号:MFCD09970974
- EINECS号:249-848-5
- FDA UNII编号:7P89L7W179
- 分子式:C25H22O10分子量:482.44
- 产品CID: 1279730
- 产品分类生物化工 → 中草药成分

- 相似结构搜索
- 产品信息参考
;
;
;
- InChIKey: CYGIJEJDYJOUAN-JSGXPVSSSA-N
- InChI=1S/C25H22O10/c1-33-16-4-9(2-3-14(16)27)18-11-7-12(20-13(18)8-34-25(20,32)24(11)31)23-22(30)21(29)19-15(28)5-10(26)6-17(19)35-23/h2-7,11,13,18,20,22-23,26-28,30,32H,
- 计算化学: 氢键受体数10.0氢键供体数5.0可旋转键数3.0
欧盟法规
ECHA物质C&L通报REACH预注册合成工艺路线路线简述
- 65666-07-1 = 29782-68-1 + 480-18-2 + 33889-69-9 + 22888-70-6 + 142796-22-3 + 1220986-69-5 + 1516881-20-1 + 1516881-22-3 + 142796-21-2 + 142797-34-0
反应条件:1.1C:1435939-45-9,S:Me2Co,24 H,45°C
标题:Preparative Method For Isosilybin Isolation Based On Enzymatic Kinetic Resolution Of Silymarin Mixture
作者:By Gazak,Radek Et Al
参考文献:Process Biochemistry (Oxford 日期:2013 卷标:48(1) 页码:184-189
专利信息
专利号:US-7598291-B2
优先权日:2004-09-02
标题 :Methods and compositions for enhancing collagen and proteoglycan synthesis in the skin
发明人:NIMNI MARCEL; HAN BO
权利人:NIMNI MARCEL; HAN BO
摘要:A composition for application to the skin can stimulate the in vivo synthesis of collagen and proteoglycans and improve the appearance of the skin, increasing its elasticity and fullness. In general, a composition according to the present invention comprises: (1) an antioxidant compound in a quantity sufficient to enhance collagen synthesis in the skin; (2) an organic penetrant in which the antioxidant compound is soluble in a sufficient quantity that a concentration of the antioxidant compound sufficient to enhance collagen synthesis can be applied topically and penetrate the skin; (3) a mixture of essential amino acids; (4) a supplemental source of sulfur; and (5) a topical pharmaceutically acceptable carrier. The antioxidant compound can be lipoic acid, a lipoic acid analogue or derivative, a bioflavonoid, a constituent of ginkgo, or an isoflavone. The organic penetrant is preferably benzyl alcohol. Other ingredients, such as esters of tocopherol and ascorbic acid, can be included.
专利号:US-2010160244-A1
优先权日:2004-09-02
标 题 :Methods and compositions for enhancing collagen, proteoglycan, and glutathione synthesis in the skin
发明人:NIMNI MARCEL; HAN BO
权利人:NIMNI MARCEL; HAN BO
摘要:A composition for application to the skin can stimulate the in vivo synthesis of collagen and proteoglycans and improve the appearance of the skin, increasing its elasticity and fullness. In general, a composition according to the present invention comprises: (1) an antioxidant compound in a quantity sufficient to enhance collagen synthesis in the skin; (2) an organic penetrant in which the antioxidant compound is soluble in a sufficient quantity that a concentration of the antioxidant compound sufficient to enhance collagen synthesis can be applied topically and penetrate the skin; (3) a mixture of essential amino acids or hydrolyzed whey protein; (4) a supplemental source of sulfur; and (5) a topical pharmaceutically acceptable carrier. The antioxidant compound can be lipoic acid or a lipoic acid analogue or derivative. The organic penetrant is preferably benzyl alcohol. Other ingredients, such as esters of tocopherol and ascorbic acid, can be included.
专利号:WO-0007607-A1
优先权日:1998-08-04
标 题:Nutrient and therapeutic compositions for the treatment of cancer
权利人:KOSBAB JOHN V
摘要:This invention relates to nutrient and therapeutic compositions for the treatment of cancer symptoms and conditions. Compositions of this invention contain a mixture of antioxidants, components that promote collagen maintenance and synthesis, components that regulate blood lipids, glucose and/or insulin, and lower homocysteine levels. Compositions also provide supplementation for nutrient (vitamin, mineral and cofactor) deficiencies to restore and maintain normal biochemical function. Cancer formulations, particularly those adapted for treatment of female cancers, can be combined with components that provide benefit in osteoporosis.
专利号:WO-2006042625-A2
优先权日:2004-10-15
标 题 :Compositions with inhibitors of the synthesis of prostaglandin and/or of leukotriene in conjunction with stimulators of the release of cutaneous neuromediators
专利号:EP-1799311-A2
优先权日:2004-10-15
标 题:Compositions with inhibitors of the synthesis of prostaglandin and/or of leukotriene in conjunction with stimulators of the release of cutaneous neuromediators
专利号:DE-102005000868-A1
优先权日:2004-10-15
标 题:Compositions with inhibitors of prostaglandin and / or leukotriene synthesis in combination with stimulants of the release of cutaneous neuromediators